V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005133 | 300003495 | 1.8 | 74 | Not known (9) | 2017-04-03 | 2017-04-04 | Gemcitabine + Capecitabine | 2 | null | 300012774 | ESPAC TRIAL |
| 300005134 | 300003496 | 1.63 | 89.6 | Curative (C) | 2016-11-03 | 2016-11-27 | FEC 100 | Y | Y | 300012816 | CISPLATIN + ETOPOSIDE |
| 300005135 | 300003497 | 1.84 | 76.6 | Palliative (P) | 2014-06-03 | 2014-06-03 | CARBOPLATIN + GEMCITABINE | 02 | N | 300012833 | CAPECITABINE + CISPLATIN |
| 300005136 | 300003497 | 1.49 | null | Palliative (P) | 2018-09-06 | 2018-09-11 | ECarboX | N | N | 300012833 | CARBOPLATIN + ETOPOSIDE |
| 300005137 | 300003498 | 1.55 | 44.6 | Palliative (P) | 2018-02-19 | 2018-02-19 | FLUOROURACIL + MITOMYCIN | 02 | N | 300012874 | DAIICHI TRIAL |
| 300005138 | 300003499 | 1.6 | 88 | Palliative (P) | 2018-08-02 | 2018-08-20 | Carboplatin + Etoposide iv&po | 02 | N | 300012923 | CARBO + FLUOROURACIL |
| 300005139 | 300003499 | 1.8 | 82 | Palliative (P) | 2017-04-10 | 2017-04-17 | Folfirinox | N | N | 300012923 | GEMCARBO |
| 300005140 | 300003499 | 1.62 | 62 | Palliative (P) | 2016-08-05 | 2016-08-08 | Gemcitabine + Capecitabine | 02 | N | 300012923 | PEMBROLIZUMAB |
| 300005141 | 300003500 | null | null | Palliative (P) | 2014-02-03 | 2014-02-03 | Dacarbazine | 02 | N | 300013851 | CAPECITABINE + GEMCITABINE |
| 300005142 | 300003500 | 1.66 | 52 | Adjuvant (A) | 2017-03-01 | 2017-03-09 | Capecitabine + Cisplatin | 02 | N | 300013851 | IPILIMUMAB + NIVOLUMAB |
| 300005143 | 300003500 | null | null | Palliative (P) | 2015-08-11 | 2015-08-11 | Carboplatin AUC 2 - 5 | N | N | 300013851 | CETUXIMAB + CISPLATIN + FU |
| 300005144 | 300008012 | 1.63 | null | Neo-adjuvant (N) | 2014-12-03 | 2014-12-21 | CAPECITABINE + GEMCITABINE | N | N | 300014246 | ESPAC TRIAL |
| 300005145 | 300003501 | 1.75 | 58.2 | Unknown (U) | 2013-11-21 | 2013-11-22 | Capecitabine + Cisplatin | 02 | N | 300014328 | DE-ESCALATE TRIAL |
| 300005146 | 300003502 | 1.7 | 51.7 | null | 2014-06-18 | 2014-06-19 | Carboplatin AUC 2 - 5 | 02 | N | 300014739 | CAPECITABINE + OXALIPLATIN |
| 300005147 | 300003503 | 1.75 | 87.5 | Curative (C) | 2014-11-08 | 2014-11-09 | Gemcitabine + Capecitabine | 02 | N | 300014867 | CARBOPLATIN + RT |
| 300005148 | 300003503 | null | null | Neo-adjuvant (N) | 2015-05-05 | 2015-05-05 | Capecitabine + Cisplatin | N | Y | 300014867 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005149 | 300003503 | 1.61 | 88.1 | Palliative (P) | 2014-09-25 | 2014-09-25 | PACLITAXEL | 02 | N | 300014867 | CISPLATIN + FLUOROURACIL + RT |
| 300005150 | 300003503 | 1.73 | 88.7 | Palliative (P) | 2015-02-28 | 2015-03-17 | GemCarbo Days 1+8 | N | N | 300014867 | ESPAC TRIAL |
| 300005151 | 300003503 | 1.71 | 92.8 | Palliative (P) | 2014-02-01 | 2014-02-02 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | 300014867 | CAPECITABINE + CISPLATIN |
| 300005152 | 300003504 | 1.78 | 93.5 | Curative (C) | 2017-10-31 | 2017-11-06 | Cisplatin + Fluorouracil + RT 5day | 1 | N | 300015149 | GEMCARBO |
| 300005153 | 300003505 | 1.64 | 75.4 | Not known (9) | 2017-01-31 | 2017-01-31 | Hydroxycarbamide | 2 | N | 300015418 | CARBOPLATIN + RT |
| 300005154 | 300003506 | 1.63 | 82.7 | Palliative (P) | 2017-03-24 | 2017-03-25 | CARBOPLATIN + RT | 02 | N | 300015539 | CARBOPLATIN + RT |
| 300005155 | 300003507 | 1.61 | 84 | Palliative (P) | 2016-08-18 | 2016-08-19 | FLUOROURACIL + MITOMYCIN | 02 | N | 300015574 | CAPECITABINE + CISPLATIN |
| 300005156 | 300003507 | 1.79 | 0 | Palliative (P) | 2017-12-02 | 2017-12-06 | CARBOPLATIN + FLUOROURACIL | N | N | 300015574 | CHOP R |
| 300005157 | 300003508 | 1.8 | 139 | Palliative (P) | 2016-05-09 | 2016-05-29 | DABRAFENIB + TRAMETINIB | N | N | 300015601 | OXALIPLATIN + MDG |
| 300005158 | 300003508 | 1.57 | 62.2 | Not known (9) | 2015-06-19 | 2015-06-19 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 300015601 | CAPECITABINE + CARBOPLATIN |
| 300005159 | 300003509 | 1.53 | 56.7 | Palliative (P) | 2016-03-12 | 2016-04-02 | GemCarbo Days 1+8 | N | N | 300015628 | CAPECITABINE + CISPLATIN + RT |
| 300005160 | 300003509 | 1.53 | 69 | Curative (C) | 2013-08-09 | 2013-08-10 | IPILIMUMAB + NIVOLUMAB | 2 | null | 300015628 | CAPECITABINE + CARBOPLATIN |
| 300005161 | 300003510 | 1.72 | 84 | Palliative (P) | 2016-06-17 | 2016-06-20 | GemCarbo Days 1+8 | 2 | N | 300016099 | GEMCARBO |
| 300005162 | 300003510 | null | 39.6 | Adjuvant (A) | 2017-11-02 | 2017-11-23 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 300016099 | FLUOROURACIL |
| 300005163 | 300003511 | 1.58 | 85.3 | Palliative (P) | 2017-01-11 | 2017-01-14 | Folfirinox | 02 | N | 300016466 | FLUOROURACIL |
| 300005164 | 300006312 | 1.81 | 86.4 | Palliative (P) | 2017-02-08 | 2017-02-11 | Carboplatin + Etoposide IV 3 day | 02 | null | 300016597 | CARBOPLATIN |
| 300005165 | 300003512 | null | 106.9 | Palliative (P) | 2018-03-27 | 2018-03-27 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 1 | N | 300016890 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005166 | 300003512 | 1.81 | 69.2 | Curative (C) | 2013-06-02 | 2013-06-06 | ESPAC-4 TRIAL | 02 | N | 300016890 | CARBO + FLUOROURACIL |
| 300005167 | 300007542 | 1.83 | 94.1 | Palliative (P) | 2014-01-03 | 2014-01-11 | Trastuzumab 21 day maintenance | 02 | N | 300017310 | CHOP R |
| 300005168 | 300003513 | 1.74 | 51.8 | Adjuvant (A) | 2015-12-29 | 2016-01-04 | Carboplatin + Etoposide iv&po | N | N | 300017371 | CARBO + FLUOROURACIL |
| 300005169 | 300003514 | 1.82 | 85.8 | Palliative (P) | 2018-03-05 | 2018-03-05 | CARBOPLATIN + FLUOROURACIL | 2 | N | 300017442 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 300005170 | 300003515 | 1.72 | 110 | Palliative (P) | null | 2016-02-18 | Carboplatin+Fluorouracil 4 or 5 day | 2 | null | 300017755 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005171 | 300003515 | 1.71 | 77.899 | Palliative (P) | 2018-02-27 | 2018-05-29 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 300017755 | CAPECITABINE + CISPLATIN |
| 300005172 | 300003516 | 1.78 | 65.6 | Palliative (P) | 2016-12-01 | 2016-12-01 | Capecitabine + Oxaliplatin 21day | N | N | 300017953 | CAPECITABINE + GEMCITABINE |
| 300005173 | 300003516 | null | 120 | Curative (C) | 2017-04-16 | 2017-05-01 | ESPAC-4 TRIAL | 02 | N | 300017953 | ABVD |
| 300005174 | 300003516 | 1.83 | 72 | Palliative (P) | 2014-09-26 | 2014-10-03 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300017953 | DOCETAXEL |
| 300005175 | 300003517 | null | 79 | Curative (C) | 2016-12-04 | 2016-12-14 | Cisplatin + Fluorouracil + RT 5day | 2 | Y | 300018331 | ESPAC TRIAL |
| 300005176 | 300006316 | 1.68 | 87.5 | Curative (C) | 2017-06-01 | 2017-06-20 | Gemcitabine + Capecitabine | 2 | Y | 300018339 | ESPAC TRIAL |
| 300005177 | 300006316 | 1.69 | 87 | Palliative (P) | 2015-03-08 | 2015-04-07 | CARBOPLATIN + RT | N | N | 300018339 | CARBOPLATIN + RT |
| 300005178 | 300006316 | 1.77 | null | Neo-adjuvant (N) | 2016-02-08 | 2016-02-08 | CHOP R - 21 days | N | N | 300018339 | CAPECITABINE + GEMCITABINE |
| 300005179 | 300003518 | 1.7 | 54.6 | null | 2017-08-10 | 2017-08-31 | Oxaliplatin + Modified de Gramont | 02 | null | 300018832 | FLUOROURACIL + MITOMYCIN |
| 300005180 | 300003518 | 1.52 | 94 | Palliative (P) | 2017-02-03 | 2017-02-19 | EOX | N | N | 300018832 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005181 | 300003519 | 1.71 | 61.7 | Palliative (P) | 2017-09-10 | 2017-09-24 | GEMCARBO | 2 | N | 300018957 | CAPECITABINE + RT |
| 300005182 | 300003520 | 1.78 | 91.2 | Palliative (P) | 2015-01-14 | 2015-01-31 | Carboplatin + Etoposide IV 3 day | N | N | 300019084 | CAPECITABINE + OXALIPLATIN |